A Study of AQUAVAN® Injection for Sedation in Elderly Patients Undergoing Flexible Bronchoscopy
Status:
Terminated
Trial end date:
2005-03-01
Target enrollment:
Participant gender:
Summary
This study was designed to demonstrate that AQUAVAN® is effective in providing adequate
sedation in patients undergoing flexible bronchoscopy as well as to assess the safety profile
of AQUAVAN versus that of midazolam. Prior to the procedure, patients receive fentanyl
citrate for pain management followed five minutes later by either AQUAVAN® Injection or
midazolam HCl for sedation. During the procedure, study personnel assess the patient's vital
signs and depth of sedation. After the procedure, the patient, physician, and an evaluator
are asked to complete satisfaction surveys.